Canandaigua National Corp cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.7% in the 1st quarter, HoldingsChannel.com reports. The fund owned 6,870 shares of the healthcare conglomerate’s stock after selling 496 shares during the period. Canandaigua National Corp’s holdings in UnitedHealth Group were worth $2,556,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the company. FMR LLC grew its holdings in shares of UnitedHealth Group by 0.6% in the fourth quarter. FMR LLC now owns 52,565,986 shares of the healthcare conglomerate’s stock valued at $18,433,841,000 after acquiring an additional 295,642 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of UnitedHealth Group by 5.2% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 38,003,233 shares of the healthcare conglomerate’s stock valued at $13,318,678,000 after acquiring an additional 1,881,407 shares in the last quarter. Alliancebernstein L.P. grew its holdings in shares of UnitedHealth Group by 5.2% in the fourth quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock valued at $4,027,639,000 after acquiring an additional 569,142 shares in the last quarter. Norges Bank bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $3,397,896,000. Finally, Bank of New York Mellon Corp grew its holdings in shares of UnitedHealth Group by 2.4% in the fourth quarter. Bank of New York Mellon Corp now owns 8,858,179 shares of the healthcare conglomerate’s stock valued at $3,106,385,000 after acquiring an additional 207,865 shares in the last quarter. 86.03% of the stock is owned by institutional investors.

In related news, Director Richard T. Burke sold 4,000 shares of the stock in a transaction on Monday, March 15th. The stock was sold at an average price of $353.32, for a total value of $1,413,280.00. Following the transaction, the director now owns 153,953 shares of the company’s stock, valued at $54,394,673.96. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 5,000 shares of the stock in a transaction on Thursday, February 11th. The shares were sold at an average price of $335.80, for a total value of $1,679,000.00. Following the completion of the transaction, the director now directly owns 153,953 shares in the company, valued at approximately $51,697,417.40. The disclosure for this sale can be found here. In the last three months, insiders sold 9,619 shares of company stock worth $3,292,774. 0.80% of the stock is owned by insiders.

Several research firms recently commented on UNH. Bank of America reiterated a “buy” rating and issued a $415.00 price objective on shares of UnitedHealth Group in a research note on Thursday, January 21st. SVB Leerink upped their price objective on UnitedHealth Group from $378.00 to $390.00 and gave the company an “outperform” rating in a research note on Monday, December 14th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $404.00 to $409.00 and gave the company a “buy” rating in a research note on Thursday, January 21st. Barclays reiterated a “buy” rating and issued a $405.00 price objective on shares of UnitedHealth Group in a research note on Sunday, January 17th. Finally, Truist increased their target price on UnitedHealth Group from $400.00 to $420.00 in a research report on Tuesday, January 5th. Five research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $387.82.

Shares of UNH stock traded up $0.43 on Thursday, reaching $366.07. The company’s stock had a trading volume of 28,988 shares, compared to its average volume of 3,420,935. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.59. UnitedHealth Group Incorporated has a 12-month low of $246.26 and a 12-month high of $380.50. The company has a market capitalization of $346.05 billion, a P/E ratio of 21.00, a PEG ratio of 1.55 and a beta of 0.74. The stock’s 50 day simple moving average is $351.44 and its 200-day simple moving average is $339.34.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 19th. The healthcare conglomerate reported $2.52 EPS for the quarter, beating the Zacks’ consensus estimate of $2.39 by $0.13. The business had revenue of $65.47 billion for the quarter, compared to analysts’ expectations of $64.98 billion. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The firm’s revenue was up 7.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.90 earnings per share. Research analysts expect that UnitedHealth Group Incorporated will post 16.75 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 23rd. Investors of record on Monday, March 15th were paid a $1.25 dividend. The ex-dividend date was Friday, March 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.37%. UnitedHealth Group’s dividend payout ratio is presently 33.09%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

Further Reading: What is a Futures Contract?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.